X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (177) 177
Publication (32) 32
Newspaper Article (9) 9
Book Chapter (4) 4
Patent (4) 4
Book / eBook (3) 3
Dissertation (3) 3
Book Review (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (90) 90
index medicus (67) 67
urology & nephrology (59) 59
child (50) 50
male (45) 45
pediatrics (45) 45
female (39) 39
nephrotic syndrome (39) 39
children (37) 37
animals (33) 33
infant (27) 27
child, preschool (25) 25
adolescent (22) 22
mice (22) 22
nephrology (22) 22
research (22) 22
article (20) 20
risk factors (19) 19
focal segmental glomerulosclerosis (18) 18
care and treatment (17) 17
kidney diseases (17) 17
health aspects (16) 16
disease (15) 15
rats (14) 14
diagnosis (12) 12
retrospective studies (12) 12
diseases (11) 11
immunosuppressive agents - therapeutic use (11) 11
therapy (11) 11
treatment outcome (11) 11
hemodialysis (10) 10
nephrotic syndrome - drug therapy (10) 10
proteinuria (10) 10
puromycin aminonucleoside (10) 10
adult (9) 9
complications and side effects (9) 9
infant, newborn (9) 9
nephrotic syndrome - pathology (9) 9
united states (9) 9
united-states (9) 9
abridged index medicus (8) 8
childhood (8) 8
disease models, animal (8) 8
epidemiology (8) 8
expression (8) 8
kidney (8) 8
medicine, research & experimental (8) 8
nephrotic syndrome - diagnosis (8) 8
time factors (8) 8
acute kidney injury - therapy (7) 7
analysis (7) 7
cells, cultured (7) 7
development and progression (7) 7
glomerulonephritis (7) 7
nephrotic syndrome - metabolism (7) 7
nephrotic syndrome - physiopathology (7) 7
pediatric (7) 7
physiological aspects (7) 7
physiology (7) 7
podocytes - drug effects (7) 7
podocytes - metabolism (7) 7
renal dialysis (7) 7
transplantation (7) 7
usage (7) 7
actin (6) 6
cell biology (6) 6
drug resistance (6) 6
glomerular filtration rate (6) 6
kidney - pathology (6) 6
management (6) 6
medicine & public health (6) 6
membranous nephropathy (6) 6
nephrotic syndrome - complications (6) 6
nephrotic syndrome - therapy (6) 6
patient outcomes (6) 6
phosphorylation (6) 6
podocytes - pathology (6) 6
proteins (6) 6
public health (6) 6
risk assessment (6) 6
risk-factors (6) 6
thrombosis (6) 6
acute renal failure (5) 5
adolescents (5) 5
age factors (5) 5
alpha-b-crystallin (5) 5
biopsy (5) 5
cell line (5) 5
climate change (5) 5
cohort studies (5) 5
crescentic glomerulonephritis (5) 5
cyclosporine (5) 5
cyclosporine - therapeutic use (5) 5
dialysis (5) 5
disease progression (5) 5
dose-response relationship, drug (5) 5
drug therapy, combination (5) 5
environmental sciences (5) 5
glomerular disease (5) 5
heat-shock proteins - metabolism (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Kidney International, ISSN 0085-2538, 12/2014, Volume 86, Issue 6, pp. 1150 - 1160
Journal Article
Pediatrics, ISSN 0031-4005, 08/2009, Volume 124, Issue 2, pp. 747 - 757
The therapeutic approach to childhood nephrotic syndrome is based on a series of studies that began with an international collaborative effort sponsored by the... 
Kidney disease | Nephrosis | Pediatric | Proteinuria | LONG-TERM | MINIMAL CHANGE | STEROID-RESISTANT | proteinuria | kidney disease | INITIAL TREATMENT | VARICELLA VACCINATION | pediatric | PREDNISOLONE THERAPY | CYCLOSPORINE THERAPY | PEDIATRICS | nephrosis | FOCAL SEGMENTAL GLOMERULOSCLEROSIS | INDUCED OBESITY | THROMBOEMBOLIC COMPLICATIONS | Glucocorticoids - therapeutic use | Kidney - pathology | Humans | Immunosuppressive Agents - therapeutic use | Antineoplastic Agents - therapeutic use | Nephrotic Syndrome - drug therapy | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Kidney Function Tests | Dose-Response Relationship, Drug | Antineoplastic Agents - adverse effects | Nephrosis, Lipoid - drug therapy | Drug Therapy, Combination | Child | Nephrotic Syndrome - diagnosis | Drug Resistance | Glucocorticoids - adverse effects | Nephrosis, Lipoid - diagnosis | Prednisone - adverse effects | Drug Administration Schedule | Nephrotic Syndrome - pathology | Combined Modality Therapy | Cyclosporine - therapeutic use | Mycophenolic Acid - adverse effects | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Nephrosis, Lipoid - pathology | Biopsy | Cyclosporine - adverse effects | Immunosuppressive Agents - adverse effects | Nephrosis, Lipoid - classification | Nephrotic Syndrome - classification | Prednisone - therapeutic use | Care and treatment | Demographic aspects | Nephrotic syndrome | Research | Children | Diseases | Pediatrics | Nephrology | Disease management | Kidney diseases | Children & youth | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Nature Reviews Nephrology, ISSN 1759-5061, 08/2012, Volume 8, Issue 8, pp. 445 - 458
The introduction of corticosteroids more than 50 years ago dramatically improved the prognosis of children with nephrotic syndrome. Corticosteroids remain the... 
UNFOLDED PROTEIN RESPONSE | STEROID-RESISTANT | ORAL GALACTOSE THERAPY | UROLOGY & NEPHROLOGY | NECROSIS-FACTOR-ALPHA | ENDOPLASMIC-RETICULUM STRESS | RANDOMIZED CONTROLLED-TRIAL | FOCAL SEGMENTAL GLOMERULOSCLEROSIS | IDIOPATHIC MEMBRANOUS NEPHROPATHY | RECEPTOR-GAMMA AGONIST | MYCOPHENOLATE-MOFETIL THERAPY | Ribonucleosides - therapeutic use | Glucocorticoids - therapeutic use | Interleukin-13 - antagonists & inhibitors | Humans | Immunosuppressive Agents - therapeutic use | Nephrotic Syndrome - metabolism | Homeostasis | Antibodies, Monoclonal - therapeutic use | Cyclophosphamide - therapeutic use | Thiazolidinediones - therapeutic use | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Anti-Inflammatory Agents - therapeutic use | Nephrotic Syndrome - therapy | Child | Antibodies, Monoclonal, Humanized - therapeutic use | Intracellular Signaling Peptides and Proteins - antagonists & inhibitors | Receptors, Notch - physiology | Rituximab | Enzyme Inhibitors - therapeutic use | Galactose - therapeutic use | Plasmapheresis | Antineoplastic Agents, Alkylating - therapeutic use | Cyclosporine - therapeutic use | Tacrolimus - therapeutic use | MAP Kinase Signaling System - drug effects | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors | Signal Transduction - physiology | Adalimumab | Unfolded Protein Response - physiology | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Immunologic Factors - therapeutic use | Case studies | Care and treatment | Usage | Prognosis | Corticosteroids | Kidney diseases | Diagnosis | Children | Health aspects | Diseases
Journal Article
JAMA, ISSN 0098-7484, 12/2016, Volume 316, Issue 23, pp. 2481 - 2482
Smoyer et al discuss Nationwide Children's Hospital's pilot program, Learn From Every Patient (LFEP). It's a local learning health system pilot program... 
MEDICINE, GENERAL & INTERNAL | BIOMEDICAL INFORMATICS | CARE | Total Quality Management | Biomedical Research - trends | Evidence-Based Medicine | Delivery of Health Care - trends | Health care | Medical research | Cerebral palsy | Pilot projects | Health services utilization | Childrens health
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, p. e0157907
Journal Article
Kidney International, ISSN 0085-2538, 02/2019, Volume 95, Issue 2, pp. 268 - 280
Journal Article
Pediatric nephrology (Berlin, Germany), ISSN 0931-041X, 07/2019, pp. 1 - 19
Children with steroid-resistant nephrotic syndrome (SRNS) are exposed to multiple cardiovascular risk factors predisposing them to accelerated atherosclerosis.... 
Lipoproteins (low density) | Puberty | Apheresis | Dyslipidemia | Lipids | Nephrotic syndrome | Lipoprotein lipase | Lipase | Risk factors | Apolipoprotein B | Lipoproteins | Molecular modelling | Hypercholesterolemia | Hypertriglyceridemia | Arteriosclerosis | Atherosclerosis | Monoclonal antibodies | Children | Lipid metabolism | Kidney diseases |